Ultraflex precision colonic stent placement for palliation of malignant colonic obstruction: a prospective multicenter study
| Autor: | Søren Meisner, Jan G. Freeman, Salvatore Comunale, Lucio Petruziello, Marc Giovannini, Georg Kähler, Roger Faroux, Cristina M. Hervoso, Alessandro Repici, Diego Fregonese, Remi Dumas, Guido Costamagna |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Male
medicine.medical_specialty Palliative care Colorectal cancer Colon medicine.medical_treatment Prosthesis Implantation Interquartile range Colon surgery Alloys Medicine Humans Radiology Nuclear Medicine and imaging Prospective Studies Prospective cohort study Survival rate Aged Aged 80 and over business.industry Palliative Care Gastroenterology Stent medicine.disease Surgery Clinical trial Survival Rate Colonic Neoplasms Female Stents business Intestinal Obstruction |
| Zdroj: | Gastrointestinal endoscopy. 66(5) |
| ISSN: | 0016-5107 |
| Popis: | Background Many patients who develop obstructive colonic symptoms secondary to inoperable colorectal cancer will require palliative treatment. A minimally invasive and potentially long-lasting approach is placement of nitinol self-expanding metal stents (SEMS). Objective To determine the effectiveness and safety of a nitinol SEMS designed for colorectal use in the palliative treatment of malignant colonic obstruction. Design Prospective multicenter clinical study. Setting Nine European study centers. Patients Forty-four patients with malignant colonic obstruction. Interventions Placement of nitinol SEMS designed for colorectal use. Main Outcome Measures Technical success, defined as accurate SEMS deployment with adequate stricture coverage, and clinical success, defined as decompression and relief of obstructive colonic symptoms maintained without intervention or serious device-related complications. Results Technical success was attained in 95% of patients, with 95% CI 85%-99%. After 6 months, the rate of clinical success was 81%, 95% CI 69%-96%. Survival at 6 months was 67%, 95% CI 54%-84%. Clinical success was maintained until death in 86% of the nonsurvivors. No perforations or SEMS-related deaths occurred. Limitation This investigation was nonrandomized and did not include a control group. Conclusions In a large prospective investigation, palliative placement of a nitinol SEMS designed for colorectal use was accomplished with a high rate of technical success. Durable clinical success was achieved in a high proportion of patients with low morbidity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect